Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The market may start the first trading session of the final quarter of the year on a positive note today. But sustaining the favorable open would depend on how the manufacturing ISM survey for September pans out.
This key gauge of the nation’s manufacturing sector has been in contractionary territory in recent months, raising doubts about the health of the thus-far robust industrial sector. But the manufacturing softness shouldn’t come as a surprise to anyone given the almost synchronized worldwide slowdown, reconfirmed by the September PMI surveys for China, the Euro-zone, and other regions of the world.
China’s official manufacturing PMI reading for September came in at 49.8, above August’s 49.2 level, but below the expected 50.2 reading. The competing private-sector measure of the same put together by the HSBC Bank ( HBC - Analyst Report ) also showed a modest improvement from the August level, but still showed an under-50 reading. We saw a similar trend play out in the Euro-zone region this morning, where the September PMI reading edged up a bit from the prior month’s level but stayed in contractionary territory for the 14th month in a row.
The U.S. economy is admittedly less trade dependent than some of the more export-centric economies like China and Germany. But export growth was a standout factor in this economic recovery and that prop may no longer be available going forward given the emerging decelerating trend in global trade volumes.
The World Trade Organization is projecting that global goods trading volumes will grow at roughly half the rate of the preceding year’s 5% pace, which itself was down from 14% growth in 2010. The recent soft freight outlook from FedEx ( FDX - Analyst Report ) was confirmation of this key emerging trend.
We will get more clarity on this soft international backdrop in the coming days as the third quarter reporting season gets underway. Expectations are for earnings to decline in the quarter, but ramp up strongly in the fourth quarter and beyond. My sense is that these fourth quarter growth expectations will get a reality check as management teams provide more visibility about business outlook.
The market made strong gains in recent months in the run-up to the Fed’s latest easing program. But can it sustain those gains in the face of a deteriorating earnings picture, particularly with QE3 now in the rearview mirror?
RELATED ARTICLES
Manufacturing Alive & Kicking?
New Top-Down Targets for 2012
What is the Biggest Threat to the Markets?
Read the full Analyst Report on HBC
Read the full Analyst Report on FDX